RHY 4.76% 6.0¢ rhythm biosciences limited

Ann: RHY Institutional Presentation, page-16

  1. 207 Posts.
    lightbulb Created with Sketch. 6
    Absolutely right. You have to assume that Otto is not going to continually forecast revenue in FY23 unless he has reasonably binding committments from one of the pathology groups to roll it out post TGA approval.
    Maybe Otto is dumb or has forgotten everything he has learned in the market over the past 40 years and thinks that if he doesnt get FY23 revenue that no one will care? He has had a number of occasions to walk the FY23 forecast back
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.